Inventor · disambiguated record
Christine F. Gelin
Also filed as: GELIN CHRISTINE · GELIN CHRISTINE F · GELIN CHRISTINE FANG
25 granted patents·4 pending applications·129 citations·filing 2012–2024
95Inventor score
Top patents by PatentIndex Score
29 records- 0196US9464084B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 11, 2016·16 cites·6 claims
- 0295US9066946B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 30, 2015·20 cites·32 claims
- 0394US10150765B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Dec 11, 2018·11 cites·18 claims
- 0494US10071988B2Substituted 1,2,3-triazoles as NR2B-selective NMDA modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Sep 11, 2018·17 cites·22 claims
- 0594US9845333B2Substituted 2-azabicycles and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Dec 19, 2017·7 cites·11 claims
- 0693US10233173B2Substituted 1,2,3-triazoles as NR2B-selective NMDA modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Mar 19, 2019·13 cites·20 claims
- 0792US11820770B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Nov 21, 2023·1 cites·20 claims
- 0891US10112937B2P2X7 modulators and methods of useJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Oct 30, 2018·11 cites·40 claims
- 0991US8969352B2Substituted 2-azabicycles and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Mar 3, 2015·12 cites·40 claims
- 1090US12247027B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Mar 11, 2025·0 cites·10 claims
- 1190US11459336B2Pyrazine carbamates and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Oct 4, 2022·2 cites·32 claims
- 1289US11530210B2Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 20, 2022·2 cites·129 claims
- 1389US11447503B2Pyridine carbamates and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 20, 2022·2 cites·33 claims
- 1489US11161846B2Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 2, 2021·2 cites·26 claims
- 1586US11225478B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jan 18, 2022·1 cites·46 claims
- 1685US10766880B2Substituted 1,2,3-triazoles as NR2B-selective NMDA modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Sep 8, 2020·2 cites·27 claims
- 1785US9611262B2Substituted 2-azabicycles and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Apr 4, 2017·6 cites·18 claims
- 1883US10703749B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 7, 2020·1 cites·6 claims
- 1978US9611277B2Substituted 2-azabicycles and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 4, 2017·1 cites·23 claims
- 2077US2025136598A1Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2174US8846656B2Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulatorsADAMS CHRISTOPHER MICHAEL·Filed 2012·Granted Sep 30, 2014·2 cites·3 claims
- 2273US12172997B2Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Dec 24, 2024·0 cites·22 claims
- 2367US2023045960A1Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2463US10183953B2Substituted 2-azabicycles and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 22, 2019·0 cites·50 claims
- 2559US9447117B2Substituted 2-azabicycles and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Sep 20, 2016·0 cites·15 claims
- 2658US2022274984A1Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2754US11618750B2Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Apr 4, 2023·0 cites·124 claims
- 2853US9505755B2Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulatorsADAMS CHRISTOPHER MICHAEL·Filed 2014·Granted Nov 29, 2016·0 cites·11 claims
- 2941US2016145247A1Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereofBELANGER DAVID B·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →